Total Payments
$501.48
2023 Payments
$35.00
Companies
12
Transactions
28
Medicare Patients
933
Medicare Billing
$139,518
Payment Breakdown by Category
Food & Beverage$501.48 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $501.48 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $126.58 | 7 | $0 (2019) |
| PFIZER INC. | $63.29 | 4 | $0 (2019) |
| Lilly USA, LLC | $46.49 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $45.93 | 3 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $44.30 | 2 | $0 (2019) |
| Amgen Inc. | $43.17 | 2 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $35.00 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $27.74 | 2 | $0 (2017) |
| SANOFI PASTEUR INC. | $19.58 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $17.92 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $35.00 | 1 | IDORSIA PHARMACEUTICALS US INC ($35.00) |
| 2019 | $77.11 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($27.18) |
| 2018 | $69.15 | 4 | AstraZeneca Pharmaceuticals LP ($17.92) |
| 2017 | $320.22 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($104.71) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INSOMNIA | ||||||
| 04/10/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $27.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.87 | General |
| 02/14/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/22/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/03/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/24/2017 | PFIZER INC. | EUCRISA (Drug), LYRICA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: DERMATOLOGY | ||||||
| 05/12/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS, VIAGRA | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/10/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: DIABETES | ||||||
| 04/26/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 04/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: DIABETES | ||||||
| 04/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: DIABETES | ||||||
| 03/24/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, FLUZONE | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: VACCINES | ||||||
| 03/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: DIABETES | ||||||
| 03/10/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 03/03/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/02/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: DIABETES | ||||||
| 02/24/2017 | Amgen Inc. | Parsabiv (Biological), Sensipar | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Nephrology | ||||||
| 02/22/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Endocrinology | ||||||
| 02/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: DIABETES | ||||||
| 02/01/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 191 | $80,434 | $17,826 |
| 2022 | 7 | 276 | 484 | $272,852 | $38,613 |
| 2021 | 6 | 295 | 457 | $286,182 | $43,704 |
| 2020 | 5 | 279 | 417 | $203,869 | $39,377 |
Total Patients
933
Total Services
1,549
Medicare Billing
$139,518
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 101 | $39,385 | $10,847 | 27.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 73 | $34,059 | $5,225 | 15.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $6,990 | $1,753 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 109 | 258 | $133,902 | $17,117 | 12.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 99 | $70,785 | $9,561 | 13.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 69 | 69 | $37,605 | $6,728 | 17.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $10,350 | $1,873 | 18.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $9,100 | $1,642 | 18.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 16 | 16 | $8,240 | $1,169 | 14.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 14 | $2,870 | $522.61 | 18.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 104 | 235 | $156,370 | $22,732 | 14.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 84 | 89 | $48,505 | $8,717 | 18.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 85 | $42,575 | $5,725 | 13.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 19 | $22,332 | $3,428 | 15.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $11,900 | $2,277 | 19.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $4,500 | $824.28 | 18.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 127 | $62,180 | $11,982 | 19.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 88 | 168 | $55,958 | $10,886 | 19.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 70 | 70 | $35,793 | $6,846 | 19.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 14 | 27 | $24,894 | $5,232 | 21.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 25 | $25,044 | $4,430 | 17.7% |
About Dr. Carlo Magtibay, MD
Dr. Carlo Magtibay, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1063795623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlo Magtibay, MD has received a total of $501.48 in payments from pharmaceutical and medical device companies, with $35.00 received in 2023. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($501.48).
As a Medicare-enrolled provider, Magtibay has provided services to 933 Medicare beneficiaries, totaling 1,549 services with total Medicare billing of $139,518. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 09/21/2011
- Last Updated 09/06/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063795623
Products in Payments
- JARDIANCE (Drug) $87.78
- CHANTIX (Drug) $46.02
- LifeVest (Device) $44.30
- QUVIVIQ (Drug) $35.00
- TRULICITY (Drug) $32.34
- SOLIQUA (Drug) $27.74
- Parsabiv (Biological) $24.60
- FLUZONE HIGH-DOSE (Drug) $19.58
- Prolia (Biological) $18.57
- BRILINTA (Drug) $17.92
- EUCRISA (Drug) $17.27
- DIFICID (Drug) $17.00
- PRADAXA (Drug) $16.93
- Victoza (Drug) $16.86
- ASMANEX (Drug) $14.62
- XARELTO (Drug) $14.62
- ZERBAXA (Drug) $14.31
- JENTADUETO (Drug) $14.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Internal Medicine $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Internal Medicine $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Internal Medicine $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Internal Medicine $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Internal Medicine $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620
Internal Medicine $18,620